Fig. 3.
The presence of humoral immunity to MV does not compromise the antitumor response to MV.
Tumor volume after intratumoral injection of MV in the presence of anti-MV antibodies (▪) as compared with that in the absence of MV antibodies (▴). The first dose of serum was administered on day −1; MV injections began on day 0. The x-axis represents time after MV injection. The y-axis represents tumor volume (cm3).
